[go: up one dir, main page]

UA96312C2 - Use of o-(3-piperidino-2-hydroxy-1-propyl)-nicotinic amidoxime for the reduction of overweight or obesity - Google Patents

Use of o-(3-piperidino-2-hydroxy-1-propyl)-nicotinic amidoxime for the reduction of overweight or obesity

Info

Publication number
UA96312C2
UA96312C2 UAA200905422A UAA200905422A UA96312C2 UA 96312 C2 UA96312 C2 UA 96312C2 UA A200905422 A UAA200905422 A UA A200905422A UA A200905422 A UAA200905422 A UA A200905422A UA 96312 C2 UA96312 C2 UA 96312C2
Authority
UA
Ukraine
Prior art keywords
overweight
piperidino
obesity
propyl
hydroxy
Prior art date
Application number
UAA200905422A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Мани Петер Литерать
Золтан Силваши
Кальман Тори
Ласло Виг
Кальман Такач
Йожеф Мандоль
Балаж Сюмеги
Шандор Бернат
Аттила Колонич
Габор Балог
Янош Эгри
Original Assignee
Н-Джин Ресерч Лабораторис Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Н-Джин Ресерч Лабораторис Инк. filed Critical Н-Джин Ресерч Лабораторис Инк.
Publication of UA96312C2 publication Critical patent/UA96312C2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention refers to the use O-(3-piperidino-2-hydroxy-1-propyl)-nicotinic amidoxime or a pharmaceutically acceptable acid addition salt thereof for the prevention of abnormal body weight gain or reduction of overweight or obesity.
UAA200905422A 2006-11-02 2007-07-23 Use of o-(3-piperidino-2-hydroxy-1-propyl)-nicotinic amidoxime for the reduction of overweight or obesity UA96312C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US85611706P 2006-11-02 2006-11-02

Publications (1)

Publication Number Publication Date
UA96312C2 true UA96312C2 (en) 2011-10-25

Family

ID=41657988

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200905422A UA96312C2 (en) 2006-11-02 2007-07-23 Use of o-(3-piperidino-2-hydroxy-1-propyl)-nicotinic amidoxime for the reduction of overweight or obesity

Country Status (4)

Country Link
CN (1) CN101646439B (en)
ES (1) ES2355680T3 (en)
UA (1) UA96312C2 (en)
ZA (1) ZA200902760B (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2452558C (en) * 2001-07-17 2009-12-22 N-Gene Research Laboratories Inc. A synergistic pharmaceutical combination for the prevention or treatment of diabetes

Also Published As

Publication number Publication date
CN101646439B (en) 2011-09-07
ES2355680T3 (en) 2011-03-30
CN101646439A (en) 2010-02-10
ZA200902760B (en) 2010-06-30

Similar Documents

Publication Publication Date Title
MX2009004538A (en) Reduction of overweight or obesity.
MX2012007375A (en) 3-keto-n-propargyl-1-aminoindan.
MX2009005604A (en) Spiroketone acetyl-coa carboxylase inhibitors.
IN2012DN01233A (en)
MX2010006241A (en) Aminotriazole derivatives as alx agonists.
WO2010091197A3 (en) Tablets for combination therapy
WO2009016462A3 (en) Substituted bicyclolactam compounds
WO2009058798A3 (en) Orally disintegrated dosage form
MX2010004705A (en) Pyridazinone derivatives and use thereof as p2x7 receptor inhibitors.
PL2086642T3 (en) Dnase for the treatment of male sub-fertility
TNSN08191A1 (en) Kinase inhibitors
UA105229C2 (en) Pharmaceutical formulation
WO2011014825A3 (en) Antiangiogenic small molecules and methods of use
WO2010066629A3 (en) Novel azaindoles
WO2010031832A3 (en) Synergistic combinations of a macrocyclic inhibitor of hcv and a thiophene-2-carboxylic acid derivative
MX2012002528A (en) Therapeutic agent for mood disorders.
TN2012000105A1 (en) Spirolactam derivatives and uses of same
WO2008129501A3 (en) Pharmaceutical compositions of duloxetine
TNSN08369A1 (en) Benzimidazole derivatives
UA97348C2 (en) HETEROCYCLIC NF-kB INHIBITORS
WO2009065090A3 (en) Pharmaceutical compositions for the treatment of conditions responsive to proteasome inhibition
IL198294A0 (en) A pharmaceutical composition having antipsychotic, antidepressant or antiepileptic activity with reduced side effect
WO2010077310A3 (en) Amide derivatives of ethacrynic acid
WO2009018551A3 (en) Therapeutic compounds
TN2012000093A1 (en) Therapeutic agent for anxiety disorders